ISHARES TR's ticker is HDV and the CUSIP is 46429B663. A total of 499 filers reported holding ISHARES TR in Q1 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,317,818 | -8.6% | 175,124 | -6.8% | 1.54% | -3.6% |
Q2 2023 | $18,946,623 | -6.6% | 187,983 | -5.8% | 1.59% | -8.0% |
Q1 2023 | $20,285,964 | -15.9% | 199,549 | -13.8% | 1.73% | -16.5% |
Q4 2022 | $24,119,262 | +30.1% | 231,384 | +14.0% | 2.07% | +19.9% |
Q3 2022 | $18,535,000 | -19.7% | 203,039 | -11.7% | 1.73% | -14.5% |
Q2 2022 | $23,085,000 | -11.9% | 229,856 | -6.3% | 2.02% | +3.1% |
Q1 2022 | $26,213,000 | +2.7% | 245,234 | -2.9% | 1.96% | +9.9% |
Q4 2021 | $25,516,000 | +1.3% | 252,667 | -5.4% | 1.79% | -2.4% |
Q3 2021 | $25,184,000 | +0.6% | 267,179 | +3.1% | 1.83% | +1.2% |
Q2 2021 | $25,023,000 | +1.8% | 259,220 | +0.1% | 1.81% | -2.5% |
Q1 2021 | $24,576,000 | +6.7% | 259,000 | -1.4% | 1.86% | +1.5% |
Q4 2020 | $23,032,000 | +5.1% | 262,717 | -3.5% | 1.83% | +1.7% |
Q3 2020 | $21,910,000 | -2.0% | 272,252 | -1.2% | 1.80% | -2.5% |
Q2 2020 | $22,355,000 | +20.5% | 275,472 | +6.3% | 1.84% | +14.3% |
Q1 2020 | $18,548,000 | -7.7% | 259,225 | +26.6% | 1.61% | -10.4% |
Q4 2019 | $20,088,000 | +7.6% | 204,839 | +3.3% | 1.80% | -1.9% |
Q3 2019 | $18,671,000 | -11.8% | 198,288 | -11.5% | 1.84% | -10.3% |
Q2 2019 | $21,171,000 | +2.5% | 224,024 | +1.2% | 2.05% | +1.9% |
Q1 2019 | $20,661,000 | +56.4% | 221,474 | +41.5% | 2.01% | +36.1% |
Q4 2018 | $13,209,000 | +64.0% | 156,539 | +75.9% | 1.48% | +86.4% |
Q3 2018 | $8,056,000 | +9.2% | 88,972 | +2.5% | 0.79% | +18.4% |
Q2 2018 | $7,379,000 | +74.4% | 86,815 | +73.3% | 0.67% | +76.3% |
Q1 2018 | $4,232,000 | +56.4% | 50,094 | +66.9% | 0.38% | +39.2% |
Q4 2017 | $2,706,000 | +146.9% | 30,012 | +135.4% | 0.27% | +141.6% |
Q3 2017 | $1,096,000 | -73.0% | 12,747 | -73.9% | 0.11% | -75.2% |
Q2 2017 | $4,058,000 | -12.4% | 48,809 | -11.6% | 0.46% | -11.0% |
Q1 2017 | $4,631,000 | +115.6% | 55,219 | +111.5% | 0.51% | +112.0% |
Q4 2016 | $2,148,000 | +3.9% | 26,112 | +2.7% | 0.24% | +6.2% |
Q3 2016 | $2,067,000 | -1.6% | 25,437 | -0.5% | 0.23% | -3.0% |
Q2 2016 | $2,100,000 | +12.1% | 25,562 | +6.5% | 0.23% | +12.0% |
Q1 2016 | $1,873,000 | – | 24,002 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVS HEALTH Corp | 624,536 | $62,722,000 | 52.01% |
Angeles Investment Advisors, LLC | 2,162,920 | $217,222,000 | 19.86% |
Bull Oak Capital, LLC | 162,500 | $16,320,000 | 15.09% |
Essex Private Wealth Management, LLC | 38,182 | $3,835,000 | 14.33% |
VAUGHAN & Co SECURITIES, INC. | 145,498 | $14,612,000 | 11.71% |
SWISS RE LTD | 564,820 | $56,725,000 | 11.35% |
Rain Capital Management, LLC | 133,852 | $13,443,000 | 9.66% |
Titus Wealth Management | 189,826 | $19,064,000 | 9.55% |
MCIA Inc | 182,506 | $18,400,000 | 9.20% |
Prostatis Group LLC | 55,911 | $5,615,175 | 8.75% |